<DOC>
	<DOCNO>NCT00657033</DOCNO>
	<brief_summary>Study investigate efficacy safety vardenafil flexible dose versus placebo male erectile dysfunction , female partner ' sexual quality life .</brief_summary>
	<brief_title>Study Investigate Efficacy Safety Vardenafil Flexible Dose Versus Placebo Males With Erectile Dysfunction</brief_title>
	<detailed_description />
	<mesh_term>Erectile Dysfunction</mesh_term>
	<mesh_term>Vardenafil Dihydrochloride</mesh_term>
	<criteria>Males ED least six month accord National Institutes Health ( NIH ) Consensus Conference December 79 , 1992 ( inability attain and/or maintain penile erection sufficient satisfactory sexual performance ) . Stable , heterosexual relationship 6 month . Males 18 year , old . Written inform consent obtain . The subject female partner must make least four attempt sexual intercourse four separate day untreated baseline period ( accord answer follow question Patient Diary : `` Was sexual activity initiate intention intercourse ? '' ) . At least 50 % attempt sexual intercourse untreated baseline period must unsuccessful , accord follow question subject diary ( least one question answer `` No '' ) : `` Were able achieve least erection ( enlargement penis ) ? `` ; `` Were able insert penis partner 's vagina ? `` ; `` Did erection last long enough successful intercourse ? '' . A ) Previous current medical condition : Any unstable medical , psychiatric , substance abuse disorder opinion Investigator likely affect subject 's ability complete study precludes subject 's participation study . Presence penile anatomical abnormality ( e.g . penile fibrosis Peyronie 's disease ) , Investigator 's opinion , would significantly impair erectile function . Primary hypoactive sexual desire . Spinal cord injury . History surgical prostatectomy ( exclude TURP ) . Retinitis pigmentosa . Unstable angina pectoris . History myocardial infarction , stroke lifethreatening arrhythmia within prior 6 month . Uncontrolled atrial fibrillation/flutter screening ( ventricular response rate &amp; # 8805 ; 100 bpm ) . Severe chronic acute liver disease , history moderate severe hepatic impairment . Clinically significant chronic haematological disease may lead priapism sickle cell anemia leukemia . Bleeding disorder . Significant active peptic ulcer disease . Resting hypotension ( rest systolic blood pressure &lt; 90 mm Hg ) hypertension ( rest systolic blood pressure &gt; 170 mm Hg rest diastolic blood pressure &gt; 110 mm Hg ) . History malignancy within past 5 year ( squamous basal cell skin cancer ) . NYHA Class III IV heart failure . History positive test Hepatitis B surface antigen ( HBsAg ) Hepatitis C. Symptomatic postural hypotension within 6 month visit 1 . B ) Concomitant medication : Subjects take nitrate nitric oxide donor . Subjects take anticoagulant , except antiplatelet agent . Subjects take androgen . Subjects take antiandrogens . Subjects take follow inhibitor cytochrome P450 3A4 : potent HIV protease inhibitor ( ritonavir , indinavir ) , antimycotic agent itraconazole ketoconazole ( topical form allow ) erythromycin . Subjects received investigational drug ( include placebo ) within 30 day Visit 1 . Use treatment ED within 7 day visit 1 study , include oral medication , vacuum device , constrictive device , injection urethral suppository . Subjects take alpha blocker C ) Abnormal laboratory value : Subjects serum total testosterone level 25 % ageadjusted low limit normal accord range test laboratory . Subjects serum creatinine &gt; 3.0 mg/dl . Elevation AST and/or ALT &gt; 3 time upper limit normal . Diabetic subject HbA1c &gt; 12 % . D ) Other Subjects age 65 old judgment investigator start 10 mg dose Subjects history unresponsiveness PDE 5 Inhibitor treatment due lack efficacy significant side effect lead discontinuation PDE 5 Inhibitor treatment . Subjects unwilling cease use vacuum device , intracavernosal injection , ViagraÂ® therapy ED study . Unwillingness subject partner make 4 attempt sexual intercourse four separate day untreated baseline period . Subjects know hypersensitivity Vardenafil , Bay 389456 ( also know SB782528 ) component investigational medication . Subjects illiterate unable understand questionnaire Patient Diary . Partners illiterate unable understand questionnaire . Subjects unwilling unable complete Patient Diary . Subjects partner , opinion investigator , would noncompliant visit schedule study procedure . Subjects unwilling refrain consume grapefruit juice product contain grapefruit juice study medication ( Canada ) .</criteria>
	<gender>Male</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2013</verification_date>
	<keyword>Erectile Dysfunction</keyword>
</DOC>